Skip to content

Fibricheck Detection cApabilities for Atrial Fibrillation

Fibricheck Detection cApabilities for Atrial Fibrillation - a Multicenter Validation Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06282380
Acronym
FDA-AF
Enrollment
330
Registered
2024-02-28
Start date
2024-02-26
Completion date
2024-06-26
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

Evaluation of accuracy of the FibriCheck Mobile Application on various smartphone devices, compared to the reference diagnosis.

Interventions

DEVICEFibriCheck Mobile Application

PPG measurement with reference diagnosis

Sponsors

Qompium NV
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 22 years old; * Capable of independently performing FibriCheck recordings (researcher-observed); * Cardiology patients, hospitalized/in-clinic or consulting the cardiac outpatient clinic, with or without a diagnosis of atrial fibrillation.

Exclusion criteria

* Individuals with cardiac pacemakers, implantable cardioverter-defibrillators, or other implanted electronic devices as these can influence the natural heart rhythm; * Individuals enrolled in another clinical trial; * Individuals with physical or medical characteristics that prevent them from successfully taking a measurement e.g. extreme callus (i.e., rough or thickened area of skin fingertip), tremor, cognitive impairment, Parkinson's disease; * Pregnant and/or nursing women.

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of the FibriCheck Mobile ApplicationThrough study completion: 1 dayAccuracy based on the reference diagnosis

Secondary

MeasureTime frameDescription
Sensitivity of the FibriCheck Mobile ApplicationThrough study completion: 1 daySensitivity based on the reference diagnosis
Specificity of the FibriCheck Mobile ApplicationThrough study completion: 1 daySpecificity based on the reference diagnosis

Countries

Belgium, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026